IMMUTEP LIMITED - Announcements

Market Cap $464.8M Add to my watchlist

Healthcare Biotechnology

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IMM	Notice of Annual General Meeting/Proxy Form		30/09/11	664.81KB	Share
IMM	Appendix 3B		21/09/11	113.51KB	Share
IMM	Prima BioMed Presentation September 2011		14/09/11	1.41MB	Share
IMM	CVac Phase III CANVAS Ovarian Cancer Clinical Update	PRICE SENSITIVE	14/09/11	192.86KB	Share
IMM	Appendix 3B		13/09/11	113.51KB	Share
IMM	Prima completes patient enrolement for CVac Phase IIb	PRICE SENSITIVE	12/09/11	96.99KB	Share
ACR +ALD ALK API ASZ BKY BSL CCP CNP CPB CUS DCG K2P FML ETM GMG HIL HUN IDL IFN ILU MCP MCR MEO MTU NDO OST PPT SRS IMM QUB RHG SFH SPL SSN STB TGA TGS ZSP	SandP Indices Announces September Quarterly Rebalance	PRICE SENSITIVE	09/09/11	62.33KB	Share
IMM	Appendix 3B		05/09/11	113.51KB	Share
IMM	Prima BioMed included in SP-ASX 300		02/09/11	98.23KB	Share
IMM	Appendix 3B		31/08/11	114.1KB	Share
IMM	Diversity Policy		31/08/11	517.88KB	Share
IMM	Preliminary Final Report	PRICE SENSITIVE	31/08/11	817.47KB	Share
IMM	Amended Appendix 3B		22/08/11	113.36KB	Share
IMM	Appendix 3B		22/08/11	113.33KB	Share
IMM	Change of Director's Interest Notice		08/08/11	44.86KB	Share
IMM	Change of Director's Interest Notice		08/08/11	44.17KB	Share
IMM	Change of Director's Interest Notice		08/08/11	44.84KB	Share
IMM	Change of Director's Interest Notice		08/08/11	44.56KB	Share
IMM	Change of Director's Interest Notice		08/08/11	44.31KB	Share
IMM	Appendix 3B		08/08/11	113.31KB	Share
IMM	EURO 4.1 MILLION GRANT TO SUPPORT CVAC	PRICE SENSITIVE	05/08/11	168.65KB	Share
IMM	Response to ASX Price Query	PRICE SENSITIVE	05/08/11	162.56KB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/11	243.54KB	Share
IMM	Appendix 3B		28/07/11	444.56KB	Share
PGL +AVE IMM	Progen Subsidiary Secures New Manufacturing Contracts	PRICE SENSITIVE	20/07/11	88.81KB	Share
IMM	Appendix 3B		19/07/11	154.12KB	Share
IMM	Change of Director's Interest Notice		19/07/11	46.59KB	Share
IMM	Change of Director's Interest Notice		19/07/11	46.7KB	Share
IMM	Appendix 3B		15/07/11	147.37KB	Share
IMM	Appendix 3B		14/07/11	144.01KB	Share
IMM	Investor Presentation		12/07/11	807.88KB	Share
IMM	Prima Newsletter		01/07/11	5.52MB	Share
IMM	Change of Address and resignation of Joint Secretary		01/07/11	43.57KB	Share
IMM	Appendix 3B		30/06/11	62.04KB	Share
IMM	Prima Raises $20 million in Share Purchase Plan		28/06/11	30.76KB	Share
IMM	Appendix 3B		20/06/11	61.63KB	Share
IMM	Potency Assay for Cvac Successfully Developed	PRICE SENSITIVE	14/06/11	79.77KB	Share
IMM	Appendix 3B		10/06/11	71.26KB	Share
IMM	Appendix 3B		02/06/11	124.51KB	Share
IMM	Appendix 3B		31/05/11	62.26KB	Share
IMM	CVac Granted Approval in DHCC	PRICE SENSITIVE	31/05/11	44.83KB	Share
IMM	Share Purchase Plan Letter of Offer		30/05/11	3.65MB	Share
IMM	Appendix 3B and S.708A Notice		26/05/11	110.08KB	Share
IMM	$21 million placement completed	PRICE SENSITIVE	26/05/11	57.81KB	Share
IMM	Prima Investor Presentation		25/05/11	392.79KB	Share
IMM	Company Information		25/05/11	629.55KB	Share
IMM	Prima announces plans to raise approx $38 million	PRICE SENSITIVE	25/05/11	63.27KB	Share
IMM	Trading Halt	PRICE SENSITIVE	25/05/11	120.11KB	Share
IMM	Appendix 3B		24/05/11	123.7KB	Share
IMM	Appendix 3B		23/05/11	62.22KB	Share
IMM	Revised Appendix 4D - December 2010	PRICE SENSITIVE	18/05/11	1.76MB	Share
IMM	Appendix 3B		13/05/11	62.24KB	Share
IMM	Appendix 3B and Section 708A Notice		09/05/11	146.65KB	Share
IMM	Joint Company Secretary Appointment		03/05/11	18.75KB	Share
IMM	Deutsche Bank Healthcare Conference Webcast Presentation		03/05/11	1.04MB	Share
IMM	Appendix 3B		29/04/11	62.56KB	Share
IMM	Appendix 4C - quarterly 3rd Quarter	PRICE SENSITIVE	27/04/11	222.73KB	Share
IMM	Appendix 3B and Section 708A		21/04/11	124.88KB	Share
IMM	Prima Awarded Japanese Patent for CVac	PRICE SENSITIVE	21/04/11	43.25KB	Share
IMM	Appendix 3B and Section 708A Notice		14/04/11	182.89KB	Share
IMM	Appendix 3B		08/04/11	63.12KB	Share
IMM	Appendix 3B		30/03/11	63.16KB	Share
IMM	Response to ASX Price Query	PRICE SENSITIVE	30/03/11	272.88KB	Share
IMM	Appendix 3B and Section 708A Notice		24/03/11	124.97KB	Share
IMM	Appendix 3B		17/03/11	63.17KB	Share
IMM	Appendix 3B		10/03/11	63.17KB	Share
IMM	Prima Biomed Investor Update		08/03/11	1.28MB	Share
IMM	Appendix 3B and 708A notice		04/03/11	125.08KB	Share
IMM	Webcast - RBC Capital Markets Healthcare Conference		02/03/11	33.06KB	Share
IMM	Webcast - RBC Capital Markets Healthcare Conference		02/03/11	24.93KB	Share
IMM	Appendix 3B		28/02/11	64.55KB	Share
IMM	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/11	4.53MB	Share
IMM	Appendix 3B and related 708A notice		24/02/11	523.05KB	Share
IMM	Expert Call Webcast		24/02/11	24.6KB	Share
IMM	Correction to Australian Conference Call Number		22/02/11	59.65KB	Share
IMM	Regulatory Scientific Advice on CVac Phase III Trial	PRICE SENSITIVE	21/02/11	3.44MB	Share
IMM	708A notice		18/02/11	55.04KB	Share
IMM	Appendix 3B		17/02/11	64.68KB	Share
IMM	Prima Biomed appoints new CFO		17/02/11	86.09KB	Share
IMM	Appendix 3B		14/02/11	64.54KB	Share
IMM	Appendix 3B		04/02/11	64.52KB	Share
IMM	Appendix 3B and Section 708A Notice		02/02/11	164.74KB	Share
IMM	CVac Phase IIb Safety Data	PRICE SENSITIVE	01/02/11	75.45KB	Share
IMM	Appendix 3B		31/01/11	86.38KB	Share
IMM	Appendix 3B		27/01/11	64.64KB	Share
IMM	Appendix 4C - Quarterly	PRICE SENSITIVE	21/01/11	187.98KB	Share
IMM	Appendix 3B		20/01/11	94.54KB	Share
IMM	Appendix 3B		14/01/11	165.33KB	Share
IMM	Appendix 3B and 708A notice		10/01/11	313.91KB	Share
IMM	Placement to Springtree and Early Termination of Facility	PRICE SENSITIVE	10/01/11	88.2KB	Share
IMM	JP Morgan Healthcare Conference Presentation		05/01/11	1.41MB	Share
IMM	Appendix 3B and Section 708A Notice		04/01/11	276.6KB	Share
IMM	Trading Policy		23/12/10	104.86KB	Share
IMM	Appendix 3B		23/12/10	96.32KB	Share
IMM	Response to ASX Price Query	PRICE SENSITIVE	23/12/10	125.94KB	Share
IMM	PRR TO PRESENT AT DEUTSCHE BANK BioFEST CONFERENCE		13/12/10	1.19MB	Share
IMM	Appendix 3Y x 5		10/12/10	471.45KB	Share
IMM	Appendix 3B and Section 708A Notice		10/12/10	247.96KB	Share
IMM	Prima Biomed Investor Update		08/12/10	393.66KB	Share
IMM	Amended Constitution		29/11/10	429.13KB	Share

IMMNotice of Annual General Meeting/Proxy Form
30/09/11		664.81KB	Share
IMMAppendix 3B
21/09/11		113.51KB	Share
IMMPrima BioMed Presentation September 2011
14/09/11		1.41MB	Share
IMMCVac Phase III CANVAS Ovarian Cancer Clinical Update
14/09/11	PRICE SENSITIVE	192.86KB	Share
IMMAppendix 3B
13/09/11		113.51KB	Share
IMMPrima completes patient enrolement for CVac Phase IIb
12/09/11	PRICE SENSITIVE	96.99KB	Share
ACR +ALD ALK API ASZ BKY BSL CCP CNP CPB CUS DCG K2P FML ETM GMG HIL HUN IDL IFN ILU MCP MCR MEO MTU NDO OST PPT SRS IMM QUB RHG SFH SPL SSN STB TGA TGS ZSPSandP Indices Announces September Quarterly Rebalance
09/09/11	PRICE SENSITIVE	62.33KB	Share
IMMAppendix 3B
05/09/11		113.51KB	Share
IMMPrima BioMed included in SP-ASX 300
02/09/11		98.23KB	Share
IMMAppendix 3B
31/08/11		114.1KB	Share
IMMDiversity Policy
31/08/11		517.88KB	Share
IMMPreliminary Final Report
31/08/11	PRICE SENSITIVE	817.47KB	Share
IMMAmended Appendix 3B
22/08/11		113.36KB	Share
IMMAppendix 3B
22/08/11		113.33KB	Share
IMMChange of Director's Interest Notice
08/08/11		44.86KB	Share
IMMChange of Director's Interest Notice
08/08/11		44.17KB	Share
IMMChange of Director's Interest Notice
08/08/11		44.84KB	Share
IMMChange of Director's Interest Notice
08/08/11		44.56KB	Share
IMMChange of Director's Interest Notice
08/08/11		44.31KB	Share
IMMAppendix 3B
08/08/11		113.31KB	Share
IMMEURO 4.1 MILLION GRANT TO SUPPORT CVAC
05/08/11	PRICE SENSITIVE	168.65KB	Share
IMMResponse to ASX Price Query
05/08/11	PRICE SENSITIVE	162.56KB	Share
IMMAppendix 4C - quarterly
29/07/11	PRICE SENSITIVE	243.54KB	Share
IMMAppendix 3B
28/07/11		444.56KB	Share
PGL +AVE IMMProgen Subsidiary Secures New Manufacturing Contracts
20/07/11	PRICE SENSITIVE	88.81KB	Share
IMMAppendix 3B
19/07/11		154.12KB	Share
IMMChange of Director's Interest Notice
19/07/11		46.59KB	Share
IMMChange of Director's Interest Notice
19/07/11		46.7KB	Share
IMMAppendix 3B
15/07/11		147.37KB	Share
IMMAppendix 3B
14/07/11		144.01KB	Share
IMMInvestor Presentation
12/07/11		807.88KB	Share
IMMPrima Newsletter
01/07/11		5.52MB	Share
IMMChange of Address and resignation of Joint Secretary
01/07/11		43.57KB	Share
IMMAppendix 3B
30/06/11		62.04KB	Share
IMMPrima Raises $20 million in Share Purchase Plan
28/06/11		30.76KB	Share
IMMAppendix 3B
20/06/11		61.63KB	Share
IMMPotency Assay for Cvac Successfully Developed
14/06/11	PRICE SENSITIVE	79.77KB	Share
IMMAppendix 3B
10/06/11		71.26KB	Share
IMMAppendix 3B
02/06/11		124.51KB	Share
IMMAppendix 3B
31/05/11		62.26KB	Share
IMMCVac Granted Approval in DHCC
31/05/11	PRICE SENSITIVE	44.83KB	Share
IMMShare Purchase Plan Letter of Offer
30/05/11		3.65MB	Share
IMMAppendix 3B and S.708A Notice
26/05/11		110.08KB	Share
IMM$21 million placement completed
26/05/11	PRICE SENSITIVE	57.81KB	Share
IMMPrima Investor Presentation
25/05/11		392.79KB	Share
IMMCompany Information
25/05/11		629.55KB	Share
IMMPrima announces plans to raise approx $38 million
25/05/11	PRICE SENSITIVE	63.27KB	Share
IMMTrading Halt
25/05/11	PRICE SENSITIVE	120.11KB	Share
IMMAppendix 3B
24/05/11		123.7KB	Share
IMMAppendix 3B
23/05/11		62.22KB	Share
IMMRevised Appendix 4D - December 2010
18/05/11	PRICE SENSITIVE	1.76MB	Share
IMMAppendix 3B
13/05/11		62.24KB	Share
IMMAppendix 3B and Section 708A Notice
09/05/11		146.65KB	Share
IMMJoint Company Secretary Appointment
03/05/11		18.75KB	Share
IMMDeutsche Bank Healthcare Conference Webcast Presentation
03/05/11		1.04MB	Share
IMMAppendix 3B
29/04/11		62.56KB	Share
IMMAppendix 4C - quarterly 3rd Quarter
27/04/11	PRICE SENSITIVE	222.73KB	Share
IMMAppendix 3B and Section 708A
21/04/11		124.88KB	Share
IMMPrima Awarded Japanese Patent for CVac
21/04/11	PRICE SENSITIVE	43.25KB	Share
IMMAppendix 3B and Section 708A Notice
14/04/11		182.89KB	Share
IMMAppendix 3B
08/04/11		63.12KB	Share
IMMAppendix 3B
30/03/11		63.16KB	Share
IMMResponse to ASX Price Query
30/03/11	PRICE SENSITIVE	272.88KB	Share
IMMAppendix 3B and Section 708A Notice
24/03/11		124.97KB	Share
IMMAppendix 3B
17/03/11		63.17KB	Share
IMMAppendix 3B
10/03/11		63.17KB	Share
IMMPrima Biomed Investor Update
08/03/11		1.28MB	Share
IMMAppendix 3B and 708A notice
04/03/11		125.08KB	Share
IMMWebcast - RBC Capital Markets Healthcare Conference
02/03/11		33.06KB	Share
IMMWebcast - RBC Capital Markets Healthcare Conference
02/03/11		24.93KB	Share
IMMAppendix 3B
28/02/11		64.55KB	Share
IMMHalf Yearly Report and Accounts
28/02/11	PRICE SENSITIVE	4.53MB	Share
IMMAppendix 3B and related 708A notice
24/02/11		523.05KB	Share
IMMExpert Call Webcast
24/02/11		24.6KB	Share
IMMCorrection to Australian Conference Call Number
22/02/11		59.65KB	Share
IMMRegulatory Scientific Advice on CVac Phase III Trial
21/02/11	PRICE SENSITIVE	3.44MB	Share
IMM708A notice
18/02/11		55.04KB	Share
IMMAppendix 3B
17/02/11		64.68KB	Share
IMMPrima Biomed appoints new CFO
17/02/11		86.09KB	Share
IMMAppendix 3B
14/02/11		64.54KB	Share
IMMAppendix 3B
04/02/11		64.52KB	Share
IMMAppendix 3B and Section 708A Notice
02/02/11		164.74KB	Share
IMMCVac Phase IIb Safety Data
01/02/11	PRICE SENSITIVE	75.45KB	Share
IMMAppendix 3B
31/01/11		86.38KB	Share
IMMAppendix 3B
27/01/11		64.64KB	Share
IMMAppendix 4C - Quarterly
21/01/11	PRICE SENSITIVE	187.98KB	Share
IMMAppendix 3B
20/01/11		94.54KB	Share
IMMAppendix 3B
14/01/11		165.33KB	Share
IMMAppendix 3B and 708A notice
10/01/11		313.91KB	Share
IMMPlacement to Springtree and Early Termination of Facility
10/01/11	PRICE SENSITIVE	88.2KB	Share
IMMJP Morgan Healthcare Conference Presentation
05/01/11		1.41MB	Share
IMMAppendix 3B and Section 708A Notice
04/01/11		276.6KB	Share
IMMTrading Policy
23/12/10		104.86KB	Share
IMMAppendix 3B
23/12/10		96.32KB	Share
IMMResponse to ASX Price Query
23/12/10	PRICE SENSITIVE	125.94KB	Share
IMMPRR TO PRESENT AT DEUTSCHE BANK BioFEST CONFERENCE
13/12/10		1.19MB	Share
IMMAppendix 3Y x 5
10/12/10		471.45KB	Share
IMMAppendix 3B and Section 708A Notice
10/12/10		247.96KB	Share
IMMPrima Biomed Investor Update
08/12/10		393.66KB	Share
IMMAmended Constitution
29/11/10		429.13KB	Share

REFRESH

First 9 10 11 12 13

(20min delay)
Last 32.0¢		Change -0.015(4.48%)		Mkt cap ! $464.8M

Open	High	Low	Value	Volume
32.0¢	32.8¢	31.5¢	$1.587M	4.950M

Buyers (Bids)

No.	Vol.	Price($)
3	35998	32.0¢

Sellers (Offers)

Price($)	Vol.	No.
32.5¢	286931	7

View Market Depth

No.	Vol.	Price($)
3	35998	0.320
15	350467	0.315
12	209876	0.310
10	151588	0.305
17	367337	0.300

Price($)	Vol.	No.
0.325	286931	7
0.330	93110	6
0.335	221989	6
0.340	484836	3
0.345	90000	2

Last trade - 16.10pm 02/10/2024 (20 minute delay)


Last 32.3¢		Change -0.015 ( 2.36 %)
Open	High	Low	Volume
32.5¢	32.8¢	31.5¢	1993992
Last updated 15.59pm 02/10/2024 ?

IMM (ASX) Chart

IMMUTEP LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available